The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
We conducted the present study to investigate the therapeutic effects of propranolol (PRO), alone and in combination with the antiresorptive agent ZOL, in a rat model of postmenopausal osteoporosis. Female Wistar rats were OVX or sham-operated at 3 months of age. Twelve weeks after surgery, rats wer...
Saved in:
Main Authors: | Deepak Kumar Khajuria, Rema Razdan, D. Roy Mahapatra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.1155/2014/586431 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Annual Zoledronic Acid for the Treatment of Osteoporosis: A Randomized Controlled Trial
by: Asif Hussain, et al.
Published: (2023-01-01) -
Characteristics Associated with Acute-Phase Response following First Zoledronic Acid Infusion in Brazilian Population with Osteoporosis
by: Bruno S. A. Ferreira, et al.
Published: (2021-01-01) -
Amelioration of Behavioural, Biochemical, and Neurophysiological Deficits by Combination of Monosodium Glutamate with Resveratrol/Alpha-Lipoic Acid/Coenzyme Q10 in Rat Model of Cisplatin-Induced Peripheral Neuropathy
by: Naini Bhadri, et al.
Published: (2013-01-01) -
HRQoL Evaluation of Pediatric Osteogenesis Imperfecta with Zoledronic Acid Therapy
by: Tri Wahyu Martanto, et al.
Published: (2023-10-01) -
Microarchitectures et architecture gothique
by: Claire Pernuit
Published: (2020-09-01)